Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times

With the emergence of the novel coronavirus disease (COVID-19) viral pandemic, there is uncertainty whether biologic agents for psoriasis may place patients at a higher risk for infection or more severe disease course. This commentary offers patient counseling recommendations based on the current av...

Descripción completa

Detalles Bibliográficos
Autores principales: Brownstone, Nicholas D., Thibodeaux, Quinn G., Reddy, Vidhatha D., Myers, Bridget A., Chan, Stephanie Y., Bhutani, Tina, Liao, Wilson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160052/
https://www.ncbi.nlm.nih.gov/pubmed/32300516
http://dx.doi.org/10.1007/s13555-020-00377-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160052/
https://www.ncbi.nlm.nih.gov/pubmed/32300516
http://dx.doi.org/10.1007/s13555-020-00377-9

Ejemplares similares